Correlation Between IMAC Holdings and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and Cue Biopharma, you can compare the effects of market volatilities on IMAC Holdings and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and Cue Biopharma.
Diversification Opportunities for IMAC Holdings and Cue Biopharma
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between IMAC and Cue is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and Cue Biopharma go up and down completely randomly.
Pair Corralation between IMAC Holdings and Cue Biopharma
Given the investment horizon of 90 days IMAC Holdings is expected to generate 0.53 times more return on investment than Cue Biopharma. However, IMAC Holdings is 1.9 times less risky than Cue Biopharma. It trades about -0.17 of its potential returns per unit of risk. Cue Biopharma is currently generating about -0.26 per unit of risk. If you would invest 122.00 in IMAC Holdings on August 29, 2024 and sell it today you would lose (18.00) from holding IMAC Holdings or give up 14.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
IMAC Holdings vs. Cue Biopharma
Performance |
| Timeline |
| IMAC Holdings |
| Cue Biopharma |
IMAC Holdings and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IMAC Holdings and Cue Biopharma
The main advantage of trading using opposite IMAC Holdings and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.The idea behind IMAC Holdings and Cue Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |